Arbutus Biopharma Corporation
DELIVERING CRISPR THERAPEUTICS WITH LIPID NANOPARTICLES
Last updated:
Abstract:
The present invention provides lipid particles comprising therapeutic nucleic acids such as gRNA that target gene expression.
Status:
Application
Type:
Utility
Filling date:
16 Mar 2020
Issue date:
10 Dec 2020